For its fourth fiscal quarter (ending December 31), Halozyme Therapeutics Inc (NASDAQ: HALO) has reported a 64% increase in E.P.S. from $0.66 a year ago to $1.08 in the current quarter. E.P.S. were $3.50 for […]
For its fourth fiscal quarter (ending December 31), Fluor Corp (NYSE: FLR) has reported a -8975% decline in E.P.S. from $-0.12 a year ago to $10.65 in the current quarter. E.P.S. were $12.48 for the […]
Expeditors International of Wash (NYSE: EXPD) has reported E.P.S. of $1.69 for its fourth fiscal quarter (ending December 31) versus $1.09 for the same period a year ago — an increase of 55%. For the […]
Daily Journal Corp (NASDAQ: DJCO) has reported E.P.S. of $7.91 for its first fiscal quarter (ending December 31) versus $9.16 for the same period a year ago — a decline of -14%. For the latest […]
Vulcan Materials Co (NYSE: VMC) has reported earnings for its fourth fiscal quarter (ending December 31) of $2.24 versus $1.73 for the same period a year ago — an increase of 29%. For the latest […]
For its fourth fiscal quarter (ending December 31), Sonoco Products Co (NYSE: SON) has reported a -170% decline in E.P.S. from $0.82 a year ago to $-0.57 in the current quarter. E.P.S. were $0.68 for […]
For its fourth fiscal quarter (ending December 31), Quad/Graphics Inc (NYSE: QUAD) has reported a -121% decline in E.P.S. from $-0.47 a year ago to $0.10 in the current quarter. For the latest four quarters […]
Neogenomics Inc (NASDAQ: NEO) has reported E.P.S. of $-0.12 for its fourth fiscal quarter (ending December 31) versus $-0.11 for the same period a year ago — an increase of 9%. For the latest four […]
For its fourth fiscal quarter (ending December 31), Genworth Financial Inc (NYSE: GNW) has reported a -102% decline in E.P.S. from $-0.47 a year ago to $0.01 in the current quarter. E.P.S. were $0.71 for […]
For its fourth fiscal quarter (ending December 31), Element Solutions Inc (NYSE: ESI) has reported a -28% decline in E.P.S. from $0.32 a year ago to $0.23 in the current quarter. E.P.S. were $1.00 for […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research